" class="no-js "lang="en-US"> Sonoma Biotherapeutics - Medtech Alert
Saturday, June 10, 2023
Sonoma Biotherapeutics | MTA

Sonoma Biotherapeutics

About Sonoma Biotherapeutics

Sonoma Biotherapeutics
Sonoma Biotherapeutics is a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases by restoring balance to the immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted and durable Treg cell therapies.

Related Story

Sonoma Biotherapeutics and Regeneron Announce Collaboration to Discover, Develop and Commercialize T Cell Therapies

March 28 2023

Sonoma Biotherapeutics and Regeneron Pharmaceuticals today announced a collaboration to apply their scientific and clinical expertise […]